Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time Is Now

Authors: Neal Shore, MD , Sarah M. Nielsen, MS , Edward D. Esplin, MD, PhD, Emmanuel S. Antonarakis, MD, Pedro C. Barata, MD, Tomasz M. Beer, MD, Himisha Beltran, MD, Alan Bryce, MD, Michael S. Cookson, MD, E. David Crawford, MD, Tanya B. Dorff, MD, Daniel J. George, MD, Elisabeth I. Heath, MD, Brian T. Helfand, MD, PhD, Maha Hussain, MD, Rana R. Mckay, MD, Alicia K. Morgans, MD, MPH, Michael J. Morris, MD, Channing J. Paller, MD, Ashley E. Ross, MD, PhD, Oliver Sartor, MD, John Shen, MD, Paul Sieber, MD, Matthew R. Smith, MD, PhD, David R. Wise, MD, PhD, Andrew J. Armstrong, MD 

Click here to read entire article

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *